Swift Biosciences Inc., an Ann Arbor-based provider of DNA and RNA library preparation and normalization kits for next-generation sequencing, and MGI Tech Co. Ltd., a subsidiary of BGI Group, have agreed to co-market Swift’s DNA and RNA library preparation products in the European and Asia Pacific markets.
With this agreement, Swift and MGI will work to enable Swift’s library preparation kits on MGI’s DNBSEQ sequencers. Swift’s 2S Turbo DNA for whole genome and targeted sequencing as well as Rapid RNA and Methyl-Seq DNA Library Kits, powered by its patented Adaptase technology, are among the first product lines selected.
The partnership will provide sequencing users with the opportunity to leverage Swift’s expertise in library generation technologies on MGI’s fast growing install base, the companies say.
Since its launch in 2018, Swift’s 2S Turbo has been adopted into several large-scale production laboratories, providing a fast, consistent, and cost-effective solution for high-throughput sequencing. Swift’s newly released Rapid RNA Library Kits enable constructing stranded RNA-Seq libraries in less time than competing offerings on the market with robust mapping.
The synergy between these two leading genomic companies will assist a larger number of laboratory and research facilities in the APAC and EMEA markets to achieve highly reproducible results at lower cost of reagents and sequencing.
“MGI is a valued partner and we will continue to grow the relationship,” says Nathan Wood, president and CEO of Swift. “We have several products launching this year and our R&D and manufacturing groups will be looking to enable the technology on the MGI platform as we continue our strategic worldwide growth.”